ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

NCI to Establish Three Grants Programs Supporting Clinical Cancer Research

February 18, 1994

Movement To Resolve Patient Care Reimbursement Problems Gains Momentum; NCI Report Adds Fuel

March 17, 1989

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

NCI, CCSG Collaborating On Electromagnetic Field Exposure Study

April 6, 1990